drugset / Trial / NCT03933618
Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function
RandomizedCrossoverTriple-blindTreatment
Summary
This study evaluates anastrazole and clomiphene in the improvement in hypogonadal symptoms and erectile function. Each subject will receive Anastrazole 1 mg/day, clomiphene 25 mg/day and placebo in randomized schedule of 8 week intervals.
Timeline
- Start
- 2015-04-02
- Primary completion
- 2017-03-08
- Completion
- 2017-03-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anastrozole | Other / unclassified | 1 mg | — |
| Subject | Clomiphene | Other / unclassified | 25 mg | — |